to detect any bound anti-glycan IgM antibodies. Following washing with wash buffer, 3, 3′, 5, 5′-tetramethylbenzidine (BD Biosciences, California, USA) was added to the plates, left for 8 min, and then the enzymatic reaction quenched via the addition of 5% sulphuric acid. The optical density (OD) was then measured at 460 nm using a Perkin Elmer Enspire™ 2300
Multilabel plate reader. The results reported are those obtained from direct OD measurements.
Statistical Analysis
Statistical significance of differences was assessed using the non-parametric Mann-Whitney U Test, using Prism v7 software (GraphPad, CA, USA), where p<0.05 was considered statistically significant.
Chemistry Experimental

General Experimental
All reactions were performed under an atmosphere of argon. Reactions were monitored by TLC analysis on Macherey-Nagel silica gel coated plastic sheets (0.20 mm with fluorescent indicator UV254) via detection by UV absorption (254 nm) where relevant and dipping in 10% H2SO4 in EtOH followed by charring or dipping in a solution of KMnO4 (0.05 M), K2CO3 (0.4 M), and NaOH (0.06%) in water. Column chromatography was performed using Pure Science silica gel (40-63 μm). All solvents were removed by evaporation under reduced pressure. High resolution mass spectra (HRMS) were recorded on an Agilent 6530 Q-TOF mass spectrometer utilising a JetStream™ electro-spray ionisation (ESI) source in positive or negative mode. Optical rotations were recorded on a Autopol II (Rudolph Research Analytical) at 589 nm (sodium D line). Infrared (IR) spectra were recorded as thin films using either a Bruker Platinum-ATR spectrometer. Nuclear magnetic resonance spectra (NMR) were obtained at 20 °C in CDCl3 or D2O using a Varian INOVA operating at 500 MHz. Chemical shifts are given in ppm (δ) relative to the solvent residual peak. NMR peak assignments were made using COSY, HSQC, and HMBC 2D experiments. Peracetylated L-rha (13, 90 mg, 0.26 mmol) and 3-azidopropanol (12, 39 mg, 0.39 mmol) were coevaporated with anhydrous toluene (2 mL) three times to remove any traces of water. The mixture was then dissolved in freshly distilled CH2Cl2 (5 mL) and cooled to 0 °C under argon, followed by the slow addition of BF3.Et2O (98 µL, 0.78 mmol).
The mixture was brought to room temperature, and then stirred for 16 hours, after which all the starting material was consumed. 3, 170.2, 170.1, 97.6, 71.1, 69.9, 69.2, 66.6, 64.7, 48.3, 28.9, 21.0, 20.9, 20.8, 17.5 General procedure for the formation of peracetylated glycosyl bromides
To a solution of the peracetylated sugar in freshly distilled CH2Cl2 (20 mL/mmol), HBr-HOAc (2 mL/mmol) was added and the solution was stirred for 4 hours at room temperature. The reaction was quenched by the addition of sat. NaHCO3 (aq.) and the product was then extracted using CH2Cl2, washed with brine and H2O, before being dried over MgSO4, filtered and concentrated. The product was then purified using silica gel flash column chromatography (10:1 → 0:1, PE : EtOAc). General procedure for the formation of thioglycosides
The peracetylated sugar was coevaporated with toluene three times to remove traces of water before being dissolved in freshly distilled CH2Cl2 (10 mL/mmol). Activated 4 Å molecular sieves were then added, followed by EtSH (2 equiv.). The reaction was then left to stir under an argon atmosphere for 45 min at 0 °C, followed by the slow addition of SnCl4 (1.5 equiv.).
The mixture was then warmed to room temperature and stirred for 18 hours. The reaction was quenched by the addition of sat. NaHCO3 (aq.) and the product extracted with CH2Cl2. The combined organic layers were washed with brine and H2O before being dried with anhydrous MgSO4, which was filtered off and the filtrate concentrated in vacuo. The products were then subjected to flash column chromatography (10:1 → 1:1, PE : EtOAc) to yield the desired thioglycosides. General procedure for the formation of β-glycosides
The glycosyl bromide and 3-azidopropanol (3 equiv.) were coevaporated with toluene three times. The mixture was then dissolved in freshly distilled CH2Cl2 (10 mL/mmol) and AgOTf (1.2 equiv.) was added and the solution was stirred under argon overnight at room temperature.
The reaction was quenched by the addition of sat. NaHCO3 (aq.) and the product was then extracted using CH2Cl2, washed with brine and H2O, before being dried over MgSO4, filtered and concentrated. The product was purified using silica gel flash column chromatography (10:1 → 0:1, PE : EtOAc).
3-Azidopropyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside.
The general procedure for the formation of β-glycosides above 8, 170.4, 169.5, 169.4, 100.9, 72.9, 72.0, 71.4, 68.5, 66.6, 62.0, 48.1, 29.1, 20.9, 20.8, 20.7(4) 7, 170.6, 170.3, 170.1, 169.8, 169.6, 100.4, 95.7, 75.5, 72.8, 72.3, 72.2, 70.1, 69.5, 68.6, 68.1, 66.6, 62.9, 61.6, 48.1, 29.1, 21.0, 20.9, 20.8, 20.7(6) 169.6, 100.4, 95.9, 95.8, 75.4, 73.9, 72.6, 72.3, 72.2, 71.9, 70.6, 70.2, 69.5, 69.1, 68.7, 68.0, 66.6, 63.0, 62.5, 61.5, 48.1, 29.1, 21.1, 21.0, 20.9, 20.8, 20.7(9), 20.7(4) General procedure for deacetylation
The peracetylated compound was dissolved in MeOH (50 mL/mmol) before NaOMe (0.1 eq) was added to the solution. The reaction mixture was allowed to stir overnight at room temperature, after which complete conversion of starting material was achieved. The solution was neutralised using Dowex H + , followed by filtration of the beads and concentration of the filtrate in vacuo to afford the product. Products were used directly without further purification. 2, 75.8, 75.6, 73.0, 69.9, 67.2, 60.7, 47.8, 28 
3-Azidopropyl α-L-rhamnopyranoside (15
3-Azidopropyl β-D-maltotrioside (20c).
The Experimental data matched those reported in literature.
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General procedure for benzylation
The deacetylated thioglycoside was coevaporated with DMF three times, leaving DMF (10 mL/mmol) on the final coevaporation. Under an argon atmosphere, BnBr (15 equiv.) and TBAI (0.15 equiv.) were added. The solution was then cooled to 0 °C and NaH (14 equiv.) was added slowly in portions. The reaction was allowed to warm to room temperature and then heated to 0, 138.4, 138.3, 138.1, 128.5-127.7, 97.4, 82.2, 80.2, 77.8, 75.8, 75.3, 73.6, 73.4, 70.5, 68.6, 64.9, 48.5, 29.0 138.9, 138.6, 138.3, 138.2, 138.1, 128.6, 128.5-128.4, 128.2, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 127.5, 127.4, 127.2, 126.9, 97.0, 96.9, 82.1, 82.0, 80.5, 79.5, 77.8, 75.7, 75.1, 74.4, 73.6, 73.4, 73.3, 72.6, 71.1, 69.9, 69.1, 68.3, 64.9, 48.5, 29.0 1073.5270; found 1073.5273.
General CuAAC procedure
To a solution of azide in 1:1 acetone : H2O, 4-pentynoic acid (2 equiv.), (+)-sodium L-ascorbate (2.5 eq) and CuSO4-5H2O (1 eq) were added and the resulting mixture was stirred at room temperature overnight. The resulting aq.ueous solution was concentrated and purified by flash silica gel and C-18 reversed-phase chromatography. 2H), 3.68 (dd, J = 12.3, 5.8 Hz, 1H), 1H), 3.46 (t, J = 8.8 Hz, 1H), 2H) 5, 146.5, 123.5, 102.1, 75.8, 75.6, 73.0, 69.5, 66.3, 60.6, 46.9, 33.3, 29.4, 20 (t, J = 8.0 Hz, 2H), 2.24-2.14 (m, 2H); 13 C NMR (125 MHz, D2O) δ 177.7, 146.8, 123.5, 102.0, 99.5, 76.6, 76.1, 74.4, 72.9, 72.7, 72.6, 71.6, 69.2, 66.4, 60.6, 60.4, 47.0. 33.5, 29.4, 20 123.5, 102.0, 99.6, 99.3, 76.8, 76.6, 76.0, 74.4, 73.2, 72.9, 72.7, 72.6, 71.6, 71.4, 71.2, 69.2, 66.4, 60.5, 60.3, 46.9, 33.8, 29.4, 20.4 7, 146.7, 123.2, 99.7, 98.0, 76.8, 73.4, 72.8, 72.6, 71.7, 71.0, 70.1, 69.2, 64.4, 60.4, 60.2, 47.3, 33.6, 28.8, 20.3 
General procedure for NHS activation of acids
TSTU (1 equiv.) and Et3N (1 equiv.) were added to a solution of the free acid in anhydrous DMF (5 mL/mmol), and the resulting solution was stirred for 1 hour at room temperature. The reaction was monitored using HRMS, which indicated complete consumption of the free acid.
The reaction mixture was then concentrated to give the activated NHS linked ester for direct use in the next step.
Conjugation with bovine serum albumin (BSA)
The NHS esters in solution (10 mg/mL in 3x PBS, pH 7.4) were added to the same volume of BSA solution (10 mg/mL in 3x PBS pH 7.4) and was stirred at room temperature for 1 h. The reaction was monitored using MALDI-TOF analysis whereby consumption of BSA indicated successful conjugation (Supplementary Figure S1) .
MALDI-TOF Analysis
To a solution of cinnapinic acid (15 mg) in MeCN:H2O (1 mL, 1/1, v/v), TFA (1 μL) was added and the mixture was vortexed for 3 min and centrifuged for 10 min, to obtain the matrix solution. A 1-2 μL aliquot of the glycoprotein (~1.0 mg/mL) was added to 20 μL of the matrix solution and a pipette was used to mix the sample. Next, 2 μL of the sample/matrix was spotted on a MALDI-plate, dried for 1 h, and measured using MALDI-TOF.
Supplementary Figure S1 . MALDI 
